<DOC>
	<DOC>NCT01197001</DOC>
	<brief_summary>Study Design : - A single center, open, randomized, single dose, two-period, two-treatment, two-sequence, crossover study Primary Objective: - To assess the bioequivalence of combination oral formulation of amlodipine/losartan versus two co-administered products containing amlodipine and losartan</brief_summary>
	<brief_title>A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan</brief_title>
	<detailed_description>Secondary Objective: - To evaluate the safety and tolerability of these formulations.</detailed_description>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Age 1855 years Healthy Caucasian volunteers Non smokers or mild smokers Exclusion criteria: Pregnancy and/or breastfeeding Participation in another clinical trial within 60 days prior to Period 1.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Amlodipine, Losartan</keyword>
</DOC>